THA Clinical Trials in Shanghai, Shanghai Municipality
11 recruitingShanghai, Shanghai Municipality, China
Showing 1–11 of 11 trials
Recruiting
Phase 3
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
Beta-ThalassemiaMyelodysplastic Syndromes (MDS)Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
Celgene665 enrolled143 locationsNCT04064060
Recruiting
Phase 3
MHB018A Treatment in Patients With Active Thyroid Eye Disease
Thyroid Associated Ophthalmopathies
Minghui Pharmaceutical (Hangzhou) Ltd108 enrolled1 locationNCT06989918
Recruiting
Not Applicable
Paired-pulse rTMS Treatment for Methamphetamine Use Disorder Based on the mPFC-Cerebellum
Methamphetamine Use Disorder
Shanghai Mental Health Center70 enrolled1 locationNCT06457230
Recruiting
Not Applicable
Indomethacin vs Diclofenac for Preventing PEP
PancreatitisERCPNon-steroidal Anti-inflammatory (NSAID)+2 more
Air Force Military Medical University, China4,050 enrolled20 locationsNCT07071441
Recruiting
Not Applicable
A Long-term Follow-up Study in Participants Who Received CS-101
Beta-Thalassemia
Children's Hospital of Fudan University5 enrolled1 locationNCT06479616
Recruiting
Phase 4
The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment.
Thyroid Associated Ophthalmopathies
Shanghai Changzheng Hospital64 enrolled2 locationsNCT07152340
Recruiting
Phase 4
Evaluation of the Efficacy and Safety Observation of IBI311 Treatment in Patients With Inactive TAO
Thyroid Associated Ophthalmopathies
Shanghai Changzheng Hospital50 enrolled1 locationNCT07152392
Recruiting
Phase 4
Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment.
Thyroid Associated Ophthalmopathies
Shanghai Changzheng Hospital96 enrolled1 locationNCT07152366
Recruiting
Establishment of Multiparametric Prediction Models for Moderate to SevereThyroid Associated Ophthalmopathy
Thyroid Associated Ophthalmopathy
Shanghai Changzheng Hospital150 enrolled1 locationNCT06590220
Recruiting
Phase 4
A Study on the Combined Use of Tocilizumab and Flupentixol-Melitracen in the Treatment of Thyroid-Associated Ophthalmopathy
Thyroid Associated Ophthalmopathy
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University60 enrolled1 locationNCT06927375
Recruiting
Phase 1Phase 2
Β-Thalassemia Treatment with KL003 Cell Injection
Transfusion Dependent Beta-Thalassemia
Kanglin Biotechnology (Hangzhou) Co., Ltd.41 enrolled2 locationsNCT06280378